| Stage | LLY | % of rev | ACAD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $24.4B | 100.00% | $308M | 100.00% | LLY ×79.22 |
| Gross profit | $20.5B | 83.88% | $280M | 90.81% | ACAD +6.9pp |
| Operating income | $8.6B | 35.28% | $38M | 12.29% | LLY +23.0pp |
| Pre-tax income | $8.4B | 34.46% | $46M | 15.09% | LLY +19.4pp |
| Net income | $6.5B | 26.44% | $32M | 10.23% | LLY +16.2pp |
| Stage | LLY | ACAD | Gap · A − B |
|---|---|---|---|
| Revenue | $24.4B100.00% | $308M100.00% | LLY ×79.22 |
| Gross profit | 83.88%$20.5B | 90.81%$280M | ACAD +6.9pp |
| Operating income | 35.28%$8.6B | 12.29%$38M | LLY +23.0pp |
| Pre-tax income | 34.46%$8.4B | 15.09%$46M | LLY +19.4pp |
| Net income |
| 26.44%$6.5B |
| 10.23%$32M |
| LLY +16.2pp |
No shared counterparties.